Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Shares lifted to record highs by lockdown easing, benign Fed

04/08/2021 | 05:52am EDT

* Europe's STOXX index up 0.3%

* S&P futures reach another peak, Nikkei lags

* Asian stock markets : https://tmsnrt.rs/2zpUAr4

* Fed sticking to stimulus, Powell set to speak

* Treasury yields dip, leaving dollar aimless

LONDON, April 8 (Reuters) - Stocks in Europe reached record highs on Thursday, buoyed by optimism in Britain over easing lockdown restrictions, while a benign outlook for U.S. interest rates was set to push Wall Street to new heights.

The European STOXX index of leading 600 companies rose 0.3%, hitting a new high of 436.66 points. London's blue chip FTSE 100 index was up 0.2%.

"It's looking good as evaluations in Europe are much lower than they are in the U.S. so there is potentially more upside. The line of least resistance for European markets is higher," said Michael Hewson, chief market analyst at CMC Markets.

"In terms of economic re-opening, there is enough optimism built in at the moment to drive markets quite a bit higher from here, and the Fed has reiterated it's going to remain on hold for a while," Hewson said.

Minutes of the Federal Reserve's last policy meeting, published on Wednesday, showed members felt the economy was still far short of target and were in no rush to scale back their $120 billion a month of bond buying.

Fed Chairman Jerome Powell speaks at an International Monetary Fund event later on Thursday and is likely to reiterate the dovish outlook.

The European Central Bank was due to publish accounts for its March 11 policy meeting amid debate about when it should start tapering its pandemic stimulus, with the euro area recovery still in doubt.

Wall Street was also set to reach fresh peaks on Thursday with e-mini futures on the S&P 500 rising 0.25% after rising to a record high, and Nasdaq futures up 0.7%

Gains by U.S. Treasuries also helped, although analysts said markets will be tested next week when the U.S. earnings seasons gets underway.

In Asia, MSCI's broadest index of Asia-Pacific shares outside Japan inched up 0.3% in quiet trade. Japan's Nikkei slipped 0.3%, not helped by news Tokyo's governor had asked for emergency measures to stem a surge of COVID-19 infections.

Yields on 10-year Treasuries have eased back to 1.669% from the recent 14-month high of 1.776%, but have struggled to break under 1.59%.

The decline coincided with a dip in the dollar index to 92.360 from its recent five-month high at 93.439.

The euro was steady at $1.1871, after rising as high as $1.1914 overnight following a surprisingly upbeat survey of European Union business activity.

In commodity markets, gold was at $1,743 an ounce after meeting resistance around $1,745.

Oil prices fell after official figures showed a big increase in U.S. gasoline stockpiles, causing concerns about demand for crude weakening in the world's biggest consumer of the resource at a time when supplies around the world are rising.

Brent fell 22 cents to $62.94 a barrel. U.S. crude lost 37 cents to $59.40 per barrel.

(Aditional reporting by Wayne Cole and Chibuike Oguh; editing by Larry King)

© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.47% 7366 Delayed Quote.1.04%
DJ INDUSTRIAL 0.90% 34035.99 Delayed Quote.10.21%
FTSE 100 0.50% 7018.82 Delayed Quote.8.10%
NASDAQ 100 1.61% 14026.194635 Delayed Quote.8.83%
NASDAQ COMP. 1.31% 14038.763174 Delayed Quote.8.93%
NIKKEI 225 0.14% 29683.37 Real-time Quote.8.01%
S&P 500 1.11% 4170.42 Delayed Quote.9.81%
All news about ASTRAZENECA PLC
07:29aASTRAZENECA  : Secures US Nod For $39 Billion Alexion Deal
06:47aEU to Focus on mRNA-based COVID-19 Jabs, Likely to Ditch AstraZeneca, Johnson..
05:18aASTRAZENECA  : CEO Says Borders Need To Open To Keep Sharing Vaccines Through CO..
05:03aASTRAZENECA  : Indian vaccine maker Serum Institute appeals to Biden to lift emb..
04:06aASTRAZENECA  : vaccine available to walk-ins
02:29aASTRAZENECA  : India extends record rise in COVID-19 cases, election rallies con..
04/15MARKET CHATTER : Elliott Management Secures 'Significant' Shareholding in GlaxoS..
04/15ANALYSIS : India shifts from mass vaccine exporter to importer, worrying the wor..
04/15MODERNA  : Fauci says he believes J&J vaccine will 'get back on track soon'
04/15ASTRAZENECA  : Quebec officials satisfied with AstraZeneca rollout despite empty..
More news
Financials (USD)
Sales 2021 30 821 M - -
Net income 2021 5 064 M - -
Net Debt 2021 11 685 M - -
P/E ratio 2021 26,1x
Yield 2021 2,80%
Capitalization 134 B 134 B -
EV / Sales 2021 4,72x
EV / Sales 2022 4,09x
Nbr of Employees 76 100
Free-Float 95,8%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 25
Average target price 129,60 $
Last Close Price 101,99 $
Spread / Highest target 62,7%
Spread / Average Target 27,1%
Spread / Lowest Target -7,66%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON1.91%422 260
ROCHE HOLDING AG-0.02%289 178
PFIZER INC.2.15%209 739
NOVARTIS AG-4.51%197 072
MERCK & CO., INC.-6.28%194 049